Status
Acquired by Bristol-Myers Squibb on April 29, 2014
Funding Received
$74.2 Million in 4 Rounds from 8 Investors
Founded:
2007
Headquarters:
South San Francisco, CA
Description:
iPierian is a drug discovery platform developing therapies for neurodegenerative diseases such as SMA, ALS and Parkinson’s.
Categories:
Biotechnology
Website:
http://www.ipierian.com

Detailed Description

Update

We are using induced pluripotent stem cells for drug discovery and development. Focused on neurodegenerative diseases such as SMA, ALS and Parkinson's, and other major unmet medical needs.

Current Team (6)

Update

Past Team (5)

Update

Board Members and Advisors (7)

Update

Acquisitions (1)

Update

Investors (8)

Update

Offices/Locations (1)

Update
  • HQ

    951 Gateway Blvd.

    South San Francisco, CA 94080

    USA

Images (1)

Update
  • C297ee884f68e6eda1b90bffd3735f9f